AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.85 Cr | ₹-1.52 Cr | ₹-2.95 Cr | ₹9.09 Cr | ₹-19 Cr |
What is the latest Cash Flow from Financing Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-1.85 Cr |
| Mar2025 | ₹-1.52 Cr |
| Mar2024 | ₹-2.95 Cr |
| Mar2023 | ₹9.09 Cr |
| Mar2022 | ₹-19 Cr |
How is Cash Flow from Financing Activities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1.85 Cr | Negative | |
| Mar2025 | ₹-1.52 Cr | Negative | |
| Mar2024 | ₹-2.95 Cr | Negative | |
| Mar2023 | ₹9.09 Cr | Positive | |
| Mar2022 | ₹-19 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹346.8 Cr | -0.9% | 38.6% | 40.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -0.9% |
38.6% |
40.8% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses